期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

耐药念珠菌的研究进展 被引量：3

The advances in study of drug-resistant candida
下载PDF
导出
摘要 耐药念珠菌的出现给感染性疾病的治疗带来了新的挑战,并已引起各界的重视。对耐药念珠菌的流行病学、耐药机制及所致感染的处理措施作一综述。
作者 宋晓静 许冰
机构地区 浙江大学医学院附属第一医院皮肤科
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2002年第11期732-734,共3页 Journal of Clinical Dermatology
关键词 耐药念珠菌 研究进展 流行病学 耐药机制
分类号 R379.4 [医药卫生—病原生物学]
  • 相关文献

参考文献20

  • 1Law D, Moore CB, Wardle HM, et al. High prevalence of antifun gal resistance in Candida spp from patients with AIDS[J]. J Antimicrob Chemother ,1994,34(5):659-668.
  • 2Graybill JR.Changing strategies for treatment of systemic mycoses[J]. Braz J Infect Dis, 2000, 4(2):47-54.
  • 3Magaldi S, Mata S, Haitung C,et al. In vitro susceptibility of 137 Candida spp. isolates from HIV positive patients to several antifungal drugs[J].Mycopathologia,2001,149(2):63-68.
  • 4Ng KP, Saw TL, Na SL, et al. Systemic Candida infection in U niversity hospital 1997-1999: the distribution of candida biotypes and antifungal susceptibility patterns[J]. Mycopathologia, 2001, 149 (3):141-146.
  • 5Pfaller MA, Jones RN, Doern GV,et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998[J]. Antimicrob A gents Chemother,2000,44(3):747-751.
  • 6Rocco TR, Reinert SE, Simms HH. Effects of fluconazole adminis tration in critically ill patients analysis of bacterial and fungal resistance[J]. Arch Surg,2000,135(2):160-165.
  • 7Redding SW, Kirkpatrick WR, Dib O,et al. The epidemiology of on-albicans Candida in oropharyngeal candidiasis in HIV patients[J]. Spec Care Dentist,2000,20(5):178-181.
  • 8Lyons CN, White TC. Transcriptional analyses of antifungal drug resistance in Candida albicans [J]. Antimicrob Agents Chemother, 2000,44(9):2296-2303.
  • 9vanden Bossche H, Marichal P, Odds FC, et al. Characterization of an azole-resistant Candida glabrata isolate [J]. Antimicrob A gents Chemother, 1992,36(12):2602-2610.
  • 10White TC. The presence of an R467K amino acid substitutionand loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans[J]. Antimicrob Agents Chemother, 1997,41 (7): 1488-1494.

同被引文献14

  • 1姚斌,金永生,潘亚菊.伏立康唑拆分方法的改进[J].第二军医大学学报,2004,25(6):691-691. 被引量：4
  • 2王晓玲.HPLC法测定抗真菌药伏立康唑的有关物质[J].西南民族大学学报（自然科学版）,2004,30(5):595-597. 被引量：3
  • 3Sofia Perea, Gennethel J. Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of voriconazole Levels in Plasma[J]. Antimicrobial Agents and Chemotherapy, 2000, 44(5): 1209-1213.
  • 4丁鼎乐.美国上市新药销售额锐减[J].上海医药,2003,24(8):358-358.
  • 5Stopher DA,Gage R.Determination of a new antifungal a gent,voriconazole,by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column[J].J.Chromatogr.B,1997,691,441-448.
  • 6L.Zhou,R.D.Glickman,N.Chen,et al,Determination of voriconazole in aqueous humor by liquid chromatography electrospray ionization-mass spectrometry[J].J.Chromatogr.B,2002,776,213-220.
  • 7沈海蓉 李中东 钟明康.氟康唑治疗细菌性感染的疗效观察[J].中国医院药学杂志,2004,23(5):308-310.
  • 8Kropshofer G, Kneer A,Edlinger M, et al. Computedtomography guided percutaneous lung biopsies and suspected fungal infections in pediatric cancer patients [ J ]. Pediatr Blood Cancer, 2014, 6(9):1620 -1624.
  • 9Pfaller MA,Castanheira M,Messer SA, et al, Comparison of EU-CAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested a-gainst Candida spp[ J]. Diagn Microbiol Infect Dis,2014,79(2): 198 -204.
  • 10Bink A, Vandenbosch D, Coenye T, et al . Superoxide dismutases are involved in Candida albicans biofilmpersistence against miconazole [J]. Antimicrob Agents Chemother, 2011,55 ( 9 ) : 4033 -4037.

引证文献3

二级引证文献21

临床皮肤科杂志
2002年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部